Core Scientific Offer
CoreWeave’s CEO maintains support for a $9 billion offer to acquire Core Scientific despite growing opposition from shareholders. The CEO believes the offer reflects the company’s true value and potential. Shareholder dissent has intensified with some arguing against the deal, citing various concerns. Nonetheless, the CEO remains committed to advancing the acquisition, asserting that it is in the best interest of both companies. As negotiations continue, the response from shareholders will likely influence the final decision on the offer.
Last updated on October 21st, 2025 at 02:21 pm
